DAFTARPUSTAKA

1. CarrBI.HepatocellularCarcinoma.Harrisonsprincipleofinternalmedicine.19 th
Edition.2015.P54443.
2. AlisonMR.Liverstemcells:implicationsforhepatocarcinogenesis.StemCellRev.
2005.1(3):25360.[Medline].
3. Badan Penelitian dan Pengembangan Kesehatan Departemen Kesehatan RI. Situasi
penyakit kanker. Jakarta: Departemen Kesehatan RI; 2013.
4. Elwood D, Pomposelli JJ. Hepatobiliary surgery: lessons learned from live donor
hepatectomy.SurgClinNorthAm.2007Oct.86(5):120717,vii.[Medline].
5. KapoorVK.Liveranatomy.DepartmentofSurgicalGastroenterology.India:Sanjay
GandhiPostGraduateInstituteofMedicalSciences.2015.
6. BudihusodoU.KarsinomaHati.BukuAjarIlmuPenyakitDalam.EdVI.Jakarta:
InternaPublishing.2014.Hal304046.
7. Bugianesi E. Nonalcoholic steatohepatitis and cancer. Clin Liver Dis. 2007 Feb.
11(1):191207,xxi.[Medline].
8. Yasui K, Hashimoto E, Komorizono Y, et al. Characteristics of patients with
nonalcoholic steatohepatitis who develop hepatocellular carcinoma. Clin
GastroenterolHepatol.2011May.9(5):42833;quize50.[Medline].
9. LiM,ZhaoH,ZhangX,etal.Inactivatingmutationsofthechromatinremodeling
gene ARID2 in hepatocellular carcinoma. Nat Genet. 2011 Aug 7. 43(9):8289.
[Medline].[FullText].
10. SetiawanPB,etal.Karsinomahepatoseluler.BukuAjarIlmuPenyakitDalam.EdII.
Surabaya:AirlanggaUniersityPress.P.137138.2015.
11. [Guideline] National Comprehensive Cancer Network. NCCN Clinical Practice
Guidelines in Oncology: Hepatobiliary Cancers. NCCN. Available at
https://www.nccn.org/professionals/physician_gls/PDF/hepatobiliary.pdf. Version
2.2017May25,2017;Accessed:August7,2017.
12. [Guideline]HeimbachJ,KulikLM,FinnR,SirlinCB,AbecassisM,RobertsLR,et
al.Aasldguidelinesforthetreatmentofhepatocellularcarcinoma.Hepatology.2017
Jan28.53(3):10202.[Medline].[FullText].
13. [Guideline] Bruix J, Sherman M, American Association for the Study of Liver
Diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011
Mar.53(3):10202.[Medline].[FullText].
14. European Association for The Study of The Liver. European Organization for
Research and Treatment of Cancer. EASLEORTC clinical practice guidelines:
managementofhepatocellularcarcinoma.JHepatol.2012Apr.56(4):90843.
15. EdgeSB,ByrdDR,ComptonCC,etal.AJCCCancerStagingManual.7thed.New
York:Springer;2010:211240.
16. Desen,Wan.TumorAbdomen.DalamBukuAjarOnkologiKlinikedisi2.Jakarta:
BalaiPenerbitFKUI.2008.
17. [Guideline]HeimbachJ,KulikLM,FinnR,SirlinCB,AbecassisM,RobertsLR,et
al.Aasldguidelinesforthetreatmentofhepatocellularcarcinoma.Hepatology.2017
Jan28.53(3):10202.[Medline].[FullText].
18. [Guideline] National Comprehensive Cancer Network. NCCN Clinical Practice
Guidelines in Oncology: Hepatobiliary Cancers. NCCN. Available at
https://www.nccn.org/professionals/physician_gls/PDF/hepatobiliary.pdf. Version
2.2017May25,2017;Accessed:September10,2017.
19. Verslype C, Rosmorduc O, Rougier P, ESMO Guidelines Working Group.
Hepatocellularcarcinoma:ESMOESDOClinicalPracticeGuidelinesfordiagnosis,
treatmentandfollowup.AnnOncol.2012Oct.23Suppl7:vii418.[Medline].
20. LokAS,EverhartJE,WrightEC,DiBisceglieAM,KimHY,SterlingRK,etal.
Maintenancepeginterferontherapyandotherfactorsassociatedwithhepatocellular
carcinoma in patients with advanced hepatitis C. Gastroenterology. 2011 Mar.
140(3):8409;quize12.[Medline].[FullText].
21. KanedaK,UenishiT,TakemuraS,etal.Theinfluenceofpostoperativeglycemic
control on recurrence after curative resection in diabetics with hepatitis C virus
relatedhepatocellularcarcinoma.JSurgOncol.2012May.105(6):60611.[Medline].